Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Fundraising
Biotech
Return of the megaround: Is biotech back from the brink?
The $100 million megaround has come roaring back in the past few weeks, but is biotech really healing?
Annalee Armstrong
Mar 21, 2023 7:00am
Fierce Biotech Fundraising Tracker: Rapport, QurAlis and more
Mar 14, 2023 7:00am
Biden: America's 'banking system is safe' after SVB bank run
Mar 13, 2023 11:00am
Volastra buys clinical cancer med from Amgen, tacks on $60M
Mar 7, 2023 7:00am
Chroma bags $135M to bolster epigenetic-focused platform
Feb 28, 2023 6:10pm
Pharnext ditches Alzheimer's plans to save cash
Feb 14, 2023 11:01am
